DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to ...
A continuous glucose monitor is a coin-sized plastic disc, a filament thinner than a hair that sits just under the skin, and ...
Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy. The healthcare giant has been swept up in a ...
OTC glucose monitors are moving into wearable health tech, but the clearest benefits remain for diabetes and prediabetes ...
Zacks Investment Research on MSN
DXCM receives FDA clearance for Stelo OTC CGM system for children
DexCom DXCM received FDA clearance for its Stelo Glucose Biosensor System for use in children aged two years and older who do ...
Senseonics is bringing the commercialization and distribution of its continuous glucose monitor products back in-house. The Germantown, MD-based company said it has signed a Memorandum of ...
Continuous glucose monitoring (CGM) devices may overestimate blood glucose levels in healthy adults, potentially leading to unnecessary dietary changes and confusion among users, according to a recent ...
Over-the-counter continuous glucose monitors have gained popularity over recent years. These devices are designed to help ...
More than 500 million people worldwide live with diabetes, making reliable continuous glucose monitoring (CGM) a critical yet ...
The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
A Japanese study conducted by a team from Nagoya University Graduate School of Medicine found that the use of continuous glucose monitoring (CGM) devices, equipped with sensors that alert diabetics ...
In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results